MedTrace Logo

Reducing Anxiety Problems Among Children Indicated to Have Developmental Language Disorder

NCT05552365 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-12-04

No results posted yet for this study

Summary

This study aims to pilot a world-first intervention, a mental health intervention augmented for children indicated with developmental language disorder (DLD). It serves as a proof-of-concept of how existing observational studies on these topics at the Centre for Research in Child Development (c.f. Tran-Sen; Gibber) can be translated into interventions. Mental health problems here are defined as anxiety type problems of social anxiety, specific phobia, separation anxiety and generalised anxiety. DLD is defined as a marked difficulty in oral language in the absence of biomedical causes (Bishop et al., 2017). This randomised pilot answers three uncertainties in preparation for a future definitive randomised control trial (RCT).

Conditions

  • Developmental Language Disorder and Language Impairment
  • Anxiety Disorders and Symptoms

Interventions

BEHAVIORAL

Adapted Cognitive Behavioural

8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder. Intervention includes psychoeducative, bodily relaxation, graded exposure, cognitive restructuring and brainstorming. Adaptations include increasing the number of visual supports, use of physical objects to illustrate concepts in addition to language.

OTHER

Treatment as Usual

Participants given a mental health brochure with contact information, where they can access services provided by mental health support service providers.

Sponsors & Collaborators

  • Nanyang Technological University

    lead OTHER

Principal Investigators

  • Shaun KY Goh, PhD · NTU-NIE

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-16
Primary Completion
2024-05-14
Completion
2024-10-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05552365 on ClinicalTrials.gov